Schechter NR - Search Results

1

Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer.

Schechter NR, Erwin WD, Yang DJ, Kim EE, Munden RF, Forster K, Taing LC, Cox JD, Macapinlac HA, Podoloff DA. Schechter NR, et al. Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1583-91. doi: 10.1007/s00259-009-1135-8. Epub 2009 Apr 25. Eur J Nucl Med Mol Imaging. 2009. PMID: 19396440 Free PMC article. Clinical Trial.

2

Can positron emission tomography improve the quality of care for head-and-neck cancer patients?

Schechter NR, Gillenwater AM, Byers RM, Garden AS, Morrison WH, Nguyen LN, Podoloff DA, Ang KK. Schechter NR, et al. Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):4-9. doi: 10.1016/s0360-3016(01)01642-x. Int J Radiat Oncol Biol Phys. 2001. PMID: 11516844 Review.

3

Assessment of antiangiogenic effect using 99mTc-EC-endostatin.

Yang DJ, Kim KD, Schechter NR, Yu DF, Wu P, Azhdarinia A, Roach JS, Kalimi SK, Ozaki K, Fogler WE, Bryant JL, Herbst R, Abbruzzes J, Kim EE, Podoloff DA. Yang DJ, et al. Among authors: schechter nr. Cancer Biother Radiopharm. 2002 Apr;17(2):233-45. doi: 10.1089/108497802753773856. Cancer Biother Radiopharm. 2002. PMID: 12030117

4

Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody.

Schechter NR, Yang DJ, Azhdarinia A, Kohanim S, Wendt R 3rd, Oh CS, Hu M, Yu DF, Bryant J, Ang KK, Forster KM, Kim EE, Podoloff DA. Schechter NR, et al. Anticancer Drugs. 2003 Jan;14(1):49-56. doi: 10.1097/00001813-200301000-00007. Anticancer Drugs. 2003. PMID: 12544258

5

Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents.

Yang DJ, Kim CG, Schechter NR, Azhdarinia A, Yu DF, Oh CS, Bryant JL, Won JJ, Kim EE, Podoloff DA. Yang DJ, et al. Among authors: schechter nr. Radiology. 2003 Feb;226(2):465-73. doi: 10.1148/radiol.2262011811. Radiology. 2003. PMID: 12563141

6

Uncertainties in physical and biological targeting with radiation therapy.

Cox JD, Schechter NR, Lee AK, Forster K, Stevens CW, Ang KK, Komaki R, Liao Z, Milas L. Cox JD, et al. Among authors: schechter nr. Rays. 2003 Jul-Sep;28(3):211-5. Rays. 2003. PMID: 15018309 Review.

7

Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck.

Schechter NR, Wendt RE 3rd, Yang DJ, Azhdarinia A, Erwin WD, Stachowiak AM, Broemeling LD, Kim EE, Cox JD, Podoloff DA, Ang KK. Schechter NR, et al. J Nucl Med. 2004 Oct;45(10):1683-7. J Nucl Med. 2004. PMID: 15471833 Free article. Clinical Trial.

8

Technologies for translational imaging using generators in oncology.

Schechter NR, Yang DJ, Azhdarinia A, Chanda M. Schechter NR, et al. Recent Pat Anticancer Drug Discov. 2007 Nov;2(3):251-8. doi: 10.2174/157489207782497253. Recent Pat Anticancer Drug Discov. 2007. PMID: 18221069 Review.

9

Advances in radiation treatments of breast cancer.

Frank SJ, McNeese MD, Strom EA, Perkins G, Salehpour M, Schechter N, Buchholz TA. Frank SJ, et al. Clin Breast Cancer. 2004 Feb;4(6):401-6. doi: 10.3816/cbc.2004.n.002. Clin Breast Cancer. 2004. PMID: 15023240 Review.

10

ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.

Love C, Desai NB, Abraham T, Banks KP, Bodei L, Boike T, Brown RKJ, Bushnell DL, DeBlanche LE, Dominello MM, Francis T, Grady EC, Hobbs RF, Hope TA, Kempf JS, Pryma DA, Rule W, Savir-Baruch B, Sethi I, Subramaniam RM, Xiao Y, Schechter NR. Love C, et al. Among authors: schechter nr. Clin Nucl Med. 2022 Jun 1;47(6):503-511. doi: 10.1097/RLU.0000000000004182. Clin Nucl Med. 2022. PMID: 35507433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page